AllianceBernstein
ACER

AllianceBernstein’s Acer Therapeutics Inc ACER Stock Holding History

AllianceBernstein’s Portfolio ACER Stock Details ACER Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-12
Closed -$2K – 3679
2014
Q1 		$2K Hold
12
– – ﹤0.01% 3469
2013
Q4 		$2K Hold
12
– – ﹤0.01% 3261
2013
Q3 		$2K Buy
+12
New +$1.6K ﹤0.01% 3282

Other funds holding ACER

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
SKK
Shepherd Kaplan Krochuk Boston, Massachusetts $119M AUM 8.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
MC
Moors & Cabot Boston, Massachusetts $2.34B AUM 30.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
GC
Guggenheim Capital Chicago, Illinois $12.9B AUM 27.3% 1-Year Est. Return
PGFC
Peapack-Gladstone Financial Corp Bedminster, New Jersey $7.82B AUM 21.06% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

AllianceBernstein's ACER Position: Q2 2014 in Review

AllianceBernstein sold out of Acer Therapeutics Inc (ACER) in Q2 2014, closing a stake of 12 shares — an estimated $2K sold.

AllianceBernstein first reported a position in ACER in Q3 2013 and held it in 3 quarters. The position peaked at $2K in Q1 2014. 16 funds tracked by Wall St. Rank hold ACER as of Q2 2014.

  • AllianceBernstein reported no remaining Acer Therapeutics Inc position as of Q2 2014 after selling out during the quarter.
  • AllianceBernstein sold 12 Acer Therapeutics Inc shares in Q2 2014, an estimated $2K.
  • AllianceBernstein first reported a position in Acer Therapeutics Inc in Q3 2013 and held it in 3 quarters.
  • AllianceBernstein's Acer Therapeutics Inc position peaked at $2K in Q1 2014.
  • 16 funds tracked by Wall St. Rank held Acer Therapeutics Inc as of Q2 2014.

Based on AllianceBernstein's 13F filing for Q2 2014, filed 13 Aug 2014.